KELLY LOSINIECKI: Open Payments
NPI 1013288448 · SOUTH BEND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$539 in 23 payments from 9 companies in 2025. Trend: 2023 $796 · 2024 $923 · 2025 $539
Food & beverage: $539
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $175 |
| Galderma Laboratories, L.P. | 2 | $120 |
| GENZYME CORPORATION | 3 | $52 |
| ABBVIE INC. | 2 | $46 |
| Lilly USA, LLC | 2 | $41 |
| Janssen Biotech, Inc. | 1 | $38 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| Mallinckrodt Hospital Products Inc. | 1 | $20 |
| Amgen Inc. | 1 | $15 |
Products named: NEMLUVIO, COSENTYX, DUPIXENT, SKYRIZI, TREMFYA, TALTZ, ACTHAR, EBGLYSS.
Industry payments across IN — which companies pay providers there.
